Development and validation of a high-performance liquid chromatographic assay for the determination of fluconazole in human whole blood using solid phase extraction

Therapeutic Drug Monitoring

Volumn 30, Issue 3, 2008, Pages 314-319

  Zhang, Shimin ^a   Mada, Sripal Reddy ^a   Torch, Marilyn ^a   Goyal, Rakesh K ^b   Venkataramanan, Raman ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Fluconazole; Immunosuppressant; Liquid chromatography; Phenacetin

Indexed keywords

ACETONITRILE; FLUCONAZOLE; PHENACETIN; WATER; ANTIFUNGAL AGENT; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; SOLVENT;

ACCURACY; ARTICLE; BLOOD SAMPLING; BLOOD VOLUME; CONTROLLED STUDY; DRUG DETERMINATION; DRUG ISOLATION; DRUG RETENTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SOLID PHASE EXTRACTION; VALIDATION STUDY; BLOOD; CALIBRATION; IMMUNOSUPPRESSIVE TREATMENT; METHODOLOGY; QUALITY CONTROL; REPRODUCIBILITY; STANDARD;

ANTIFUNGAL AGENTS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLUCONAZOLE; HUMANS; IMMUNOSUPPRESSION; INDICATORS AND REAGENTS; QUALITY CONTROL; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SOLVENTS;

EID: 47249084640     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e31816c7404     Document Type: Article

References (10)

1. Bennets JE. Antimicrobial agents: antifungal agents. In: Hardman JG, Limbird LE, Molinoff PB, et al, eds. Goodman & Gillman's the Pharmacological Basis of Therapeutics. New York: McGraw-Hill; 1996: 1183-1184.
2. Humphrey MJ, Jevons S, Tarbit MH. Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans. Antimicrob Agents Chemother. 1985;28:648-653.
3. Kim SS, Im HT, Kang IM, et al. An optimized analytical method of fluconazole in human plasma by high-performance liquid chromatography with ultraviolet detection and its application to a bioequivalence study. J Chromatogr B. 2007;852:174-179.
4. Cociglio M, Brandissou S, Alric R, et al. High-performance liquid chromatographic determination of fluconazole in plasma. J Chromatogr B. 1996;686:11-17.
5. Koks CH, Rosing H, Meenhorst PL, et al. High-performance liquid chromatographic determination of the antifungal drug fluconazole in plasma and saliva of human immunodeficiency virus-infected patients. J Chromatogr B. 1995;663:345-351.
6. Wattananat T, AkarawutW. Validated HPLC method for the determination of fluconazole in human plasma. Biomed Chromatogr. 2006;20:1-3.
7. Li ZW, Guo P, Ye LM, et al. Determination of fluconazole by direct injection of plasma and high performance liquid chromatography with column switching. Yao Xue Xue Bao. 1994;29:773-777.
8. Wallace JE, Harris SC, Gallegos J, et al. Assay of fluconazole by highperformance liquid chromatography with a mixed-phase column. Antimicrob Agents Chemother. 1992;36:603-606.
9. Majcherczyk PA, Moreillon P, Decosterd LA, et al. Single-step extraction of fluconazole from plasma by ultra-filtration for the measurement of its free concentration by high performance liquid chromatography. J Pharm Biomed Anal. 2002;28:645-651.
10. Moraes LA, Lerner FE, Moraes ME, et al. Fluconazole bioequivalence study: quantification by tandem mass spectrometry. Ther Drug Monit. 1999;21:200-207.